(Q73702097)
Statements
Interferon-beta (INF-beta) antibodies in interferon-beta1a- and interferon-beta1b-treated multiple sclerosis patients. Prevalence, kinetics, cross-reactivity, and factors enhancing interferon-beta immunogenicity in vivo (English)
Perini P
Facchinetti A
Bulian P
Massaro AR
Pascalis DD
Bertolotto A
Biasi G